OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models
Michelle P. Clark, T Huynh, Shringar Rao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 7
Open Access | Times Cited: 8
Michelle P. Clark, T Huynh, Shringar Rao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 7
Open Access | Times Cited: 8
Showing 8 citing articles:
Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges
Abdullah Al Jabri, Jibran Ahmad Khan, Bader Taftafa, et al.
Bioengineering (2024) Vol. 11, Iss. 4, pp. 346-346
Open Access | Times Cited: 4
Abdullah Al Jabri, Jibran Ahmad Khan, Bader Taftafa, et al.
Bioengineering (2024) Vol. 11, Iss. 4, pp. 346-346
Open Access | Times Cited: 4
Organoids and organs-on-chips: Recent advances, applications in drug development, and regulatory challenges
Liangbin Zhou, Jingjing Huang, Cun Li, et al.
Med (2025) Vol. 6, Iss. 4, pp. 100667-100667
Closed Access
Liangbin Zhou, Jingjing Huang, Cun Li, et al.
Med (2025) Vol. 6, Iss. 4, pp. 100667-100667
Closed Access
Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening
H. Fang, Haoying Xu, Jiong Yu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 794-794
Open Access | Times Cited: 3
H. Fang, Haoying Xu, Jiong Yu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 794-794
Open Access | Times Cited: 3
Overview of the development of HBV small molecule inhibitors
Huihui Yang, Weiwei Yao, Jinfei Yang
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115128-115128
Closed Access | Times Cited: 3
Huihui Yang, Weiwei Yao, Jinfei Yang
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115128-115128
Closed Access | Times Cited: 3
New Treatment Options in Chronic Hepatitis B: How Close Are We to Cure?
Pınar Korkmaz, Ali Aşan, Faruk Karakeçili, et al.
Infectious Diseases and Clinical Microbiology (2023) Vol. 5, Iss. 4, pp. 267-280
Open Access | Times Cited: 3
Pınar Korkmaz, Ali Aşan, Faruk Karakeçili, et al.
Infectious Diseases and Clinical Microbiology (2023) Vol. 5, Iss. 4, pp. 267-280
Open Access | Times Cited: 3
The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells
Jingmin Ji, Zhiqin Zhang, Qing Peng, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 3
Jingmin Ji, Zhiqin Zhang, Qing Peng, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 3
An orally-available monovalent SMAC mimetic compound as a broad-spectrum antiviral
Miao Mei, Maria Antonietta Impagnatiello, Jun Jiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 1, pp. 69-75
Open Access | Times Cited: 1
Miao Mei, Maria Antonietta Impagnatiello, Jun Jiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 1, pp. 69-75
Open Access | Times Cited: 1
Killing in self-defense: proapoptotic drugs to eliminate intracellular pathogens
Jan Schaefer, William Clow, Reet Bhandari, et al.
Current Opinion in Immunology (2022) Vol. 79, pp. 102263-102263
Closed Access | Times Cited: 2
Jan Schaefer, William Clow, Reet Bhandari, et al.
Current Opinion in Immunology (2022) Vol. 79, pp. 102263-102263
Closed Access | Times Cited: 2
